Cited by 110Genomics and Rare DiseasesGenetic Associations and EpidemiologyGenetics and Neurodevelopmental Disorders

Quantifying the impact of rare and ultra-rare coding variation across the phenotypic spectrum

Open access
Ganna, Andrea, Satterstrom, F. Kyle, Zekavat, Seyedeh M., Das, Indraniel, Kurki, Mitja I., Churchhouse, Claire, Alfoldi, Jessica, Martin, Alicia R. +36 more·2018·The American Journal of Human Genetics

Published version of a preprint

Abstract

There is a limited understanding about the impact of rare protein-truncating variants across multiple phenotypes. We explore the impact of this class of variants on 13 quantitative traits and 10 diseases using whole-exome sequencing data from 100,296 individuals. Protein-truncating variants in genes intolerant to this class of mutations increased risk of autism, schizophrenia, bipolar disorder, intellectual disability, and ADHD. In individuals without these disorders, there was an association with shorter height, lower education, increased hospitalization, and reduced age at enrollment. Gene sets implicated from GWASs did not show a significant protein-truncating variants burden beyond what was captured by established Mendelian genes. In conclusion, we provide a thorough investigation of the impact of rare deleterious coding variants on complex traits, suggesting widespread pleiotropic risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2018.05.002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rare, large-effect variants that increase risk for neurodevelopmental and neuropsychiatric disorders are also associated with deleterious effects on cognition, and ASD is no exception.

    “Rare, large-effect variants that increase risk for neurodevelopmental and neuropsychiatric disorders are also associated with deleterious effects on cognition,28, 29, 30 and ASD is no exception.”

    From Insufficient Evidence for “Autism-Specific” Genes (2020) · cites this paper as [30]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 28 · Cited by 110

Research works printed but not linked: 3

  1. [6]6. [Robinson, E.B., St Pourcain, B., Anttila, V., Kosmicki, J.A., Bulik-Sullivan, B., Grove, J., Maller, J., Samocha, K.E., Sanders, S.J., Ripke, S., et al.; iPSYCH-SSI-Broad Autism Group (2016). Genetic risk for autism spectrum disorders and neuropsychi-](http://refhub.elsevier.com/S0002-9297(18)30163-0/sref6)
  2. [13]13. [Wu,M.C.,Lee,S.,Cai,T.,Li,Y.,Boehnke,M.,andLin,X.(2011). Rare-variant association testing for sequencing data with the sequencekernelassociationtest.Am.J.Hum.Genet. 89 , 82-93.](http://refhub.elsevier.com/S0002-9297(18)30163-0/sref13)
  3. [24]24. [Voight, B.F., Peloso, G.M., Orho-Melander, M., FrikkeSchmidt, R., Barbalic, M., Jensen, M.K., Hindy, G., Ho ´ lm, H., Ding, E.L., Johnson, T., et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380 , 572-580.](http://refhub.elsevier.com/S0002-9297(18)30163-0/sref24)

Authors
Ganna, A., Satterstrom, F. K., Zekavat, S. M., Das, I., Kurki, M. I., Churchhouse, C., Alfoldi, J., Martin, A. R., Havulinna, A. S., Byrnes, A., Thompson, W. K., Nielsen, P. R., Karczewski, K. J., Saarentaus, E., Rivas, M. A., Gupta, N., Pietiläinen, O., Emdin, C. A., Lescai, F., Bybjerg-Grauholm, J., Flannick, J., Mercader, J. M., Udler, M., Laakso, M., Salomaa, V., Hultman, C., Ripatti, S., Hämäläinen, E., Moilanen, J. S., Körkkö, J., Kuismin, O., Nordentoft, M., Hougaard, D. M., Mors, O., Werge, T., Mortensen, P. B., MacArthur, D., Daly, M. J., Sullivan, P. F., Locke, A. E., Palotie, A., Børglum, A. D., Kathiresan, S., & Neale, B. M.
Affiliations
  • Broad Institute (US)
  • Washington University in St. Louis (US)
  • University of Helsinki (FI)
  • Oslo University Hospital (NO)
  • Aarhus University (DK)
  • Stanford University (US)
  • University of Eastern Finland (FI)
  • Finnish Institute for Health and Welfare (FI)
  • Karolinska Institutet (SE)
  • Oulu University Hospital (FI)
  • University of Copenhagen (DK)
  • Statens Serum Institut (DK)
  • Aarhus University Hospital (DK)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
  • Ganna, Andrea
  • Neale, Benjamin M.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2018-06
Volume
102
Issue
6
Pages
1204-1211
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2916821655
Cited by
110
References
28
Citations by year
2026: 6 · 2025: 9 · 2024: 7 · 2023: 13 · 2022: 18 · 2021: 10 · 2020: 21 · 2019: 20 · 2018: 5 · 2017: 1
FWCI
8.59
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • UNC Libraries
  • WOS
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (1U54DK105566-02)
  • Alexander and Margaret Stewart Trust
  • National Institute of Mental Health (1R01MH101244-02, RC2 MH089905, 1U01MH105666-01, R01 MH077139)
  • Sylvan C. Herman Foundation
  • Knut och Alice Wallenbergs Stiftelse (2015.0327)
  • Vetenskapsrådet (2016-00250)
  • Sydäntutkimussäätiö
  • National Human Genome Research Institute (R01 HG006855, U54 HG003067)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
truncating mutations, ultra-rare variants, monogenic disorders, autism spectrum disorder, schizophrenia, bipolar disorder, intellectual disability, attention deficit hyperactivity disorder, quantitative traits, height, educational attainment, hospitalization, pleiotropy, genetic burden, exome sequencing
MeSH terms
Ethnicity, Humans, Mutation, Phenotype, Proteins, Open Reading Frames, Genetic Predisposition to Disease, Databases, Genetic, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review